Stephen Davis - Jun 15, 2022 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC (BLCM)

Role
Director
Signature
/s/ Richard A. Fair, Attorney-in-Fact
Stock symbol
BLCM
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/16/2022, 02:49 PM
Previous filing
May 3, 2022
Next filing
Sep 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Stock Option (right to buy) Award $0 +15K $0.00 15K Jun 15, 2022 Common Stock 15K $1.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date.